Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource, requires expanding healthcare providers’ adoption of PrEP into clinical practice. This qualitative study explored PrEP providers’ firsthand experiences relative to six commonly-cited barriers to prescription – financial coverage, implementation logistics, eligibility determination, adherence concerns, side effects, and anticipated behavior change (risk compensation) – as well as their recommendations for training PrEP-inexperienced providers. U.S.-based PrEP providers were recruited via direct outreach and referral from colleagues and other participants (2014-2015). One-on-one interviews were conducted in person or by phone, transcribed, and...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific ...
The United States’ initiative to End the HIV Epidemic by 2030 includes a primary goal to reduce new ...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV acquisition, y...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
Despite high pre-exposure prophylaxis (PrEP) acceptability among people who inject drugs (PWID) and ...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background:Pre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention ...
Despite compelling evidence behind the efficacy of pre-exposure prophylaxis (PrEP) in preventing hum...
BackgroundPre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention o...
BACKGROUND: In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exp...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific ...
The United States’ initiative to End the HIV Epidemic by 2030 includes a primary goal to reduce new ...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV acquisition, y...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
Despite high pre-exposure prophylaxis (PrEP) acceptability among people who inject drugs (PWID) and ...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background:Pre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention ...
Despite compelling evidence behind the efficacy of pre-exposure prophylaxis (PrEP) in preventing hum...
BackgroundPre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention o...
BACKGROUND: In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exp...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific ...
The United States’ initiative to End the HIV Epidemic by 2030 includes a primary goal to reduce new ...